| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |